Is Metronidazole (Flagyl) safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metronidazole Use During Pregnancy

Metronidazole should be avoided during the first trimester of pregnancy but can be safely used after the first trimester when clinically indicated for conditions such as bacterial vaginosis, trichomoniasis, or other anaerobic infections. 1, 2

Safety Profile and Recommendations

  • First trimester use:

    • Contraindicated during the first trimester according to CDC guidelines 1
    • Clindamycin cream 2% applied intravaginally at bedtime for 7 days is the preferred treatment for bacterial vaginosis during this period 1
  • Second and third trimester use:

    • Safe to use after the first trimester 1
    • For bacterial vaginosis: 500mg orally twice daily for 7 days 1
    • For trichomoniasis: 2g orally in a single dose 1
    • Can be given for pouchitis, perianal Crohn's disease, or intra-abdominal abscesses 3

Evidence on Fetal Safety

  • FDA classifies metronidazole as Pregnancy Category B 2
  • Animal reproduction studies have shown no evidence of impaired fertility or harm to the fetus at doses up to five times the human dose 2
  • No fetotoxicity was observed in pregnant mice at 20 mg/kg/day (approximately 1.5 times the most frequently recommended human dose) 2
  • A prospective controlled cohort study found no difference in the rate of major malformations between metronidazole-exposed pregnancies and controls (1.6% vs. 1.4%) 4

Important Precautions

  • Metronidazole crosses the placental barrier rapidly 2
  • Patients should avoid alcohol during treatment and for 24 hours afterward to prevent disulfiram-like reactions 1
  • Common side effects include gastrointestinal disturbances, metallic taste, and potential for peripheral neuropathy with prolonged use 1

Clinical Considerations for Specific Conditions

Bacterial Vaginosis

  • Untreated BV in pregnancy increases risk of preterm birth, low birth weight, and chorioamnionitis 1
  • After first trimester, metronidazole 500mg orally twice daily for 7 days (95% cure rate) is recommended 1

Trichomoniasis

  • For treatment after first trimester: metronidazole 2g orally in a single dose 1
  • Note that one study found that metronidazole treatment for asymptomatic trichomoniasis between 16-23 weeks did not reduce preterm birth and showed potential harm 5

Other Anaerobic Infections

  • Metronidazole can be used for pouchitis, perianal Crohn's disease, or intra-abdominal abscesses 3
  • Amoxicillin-clavulanic acid is an alternative safe option during pregnancy 3

Important Cautions

  • A meta-analysis found that metronidazole as the only antibiotic administered in the second trimester was associated with a higher rate of preterm delivery in high-risk populations (OR 1.31; 95% CI 1.08-1.58) 6
  • Due to concerns about mutagenicity, use during pregnancy should be restricted to cases where alternative treatments have been inadequate 2, 7
  • Follow-up evaluation 1 month after treatment completion is recommended for high-risk pregnant women 1

When treatment for bacterial vaginosis or trichomoniasis is necessary during pregnancy, the timing of therapy and selection of antimicrobial agent should be carefully considered based on trimester, severity of infection, and potential risks versus benefits.

References

Guideline

Bacterial Vaginosis and Urinary Tract Infection in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Interventions for trichomoniasis in pregnancy.

The Cochrane database of systematic reviews, 2011

Research

The effect of second-trimester antibiotic therapy on the rate of preterm birth.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2007

Research

Symposium on antimicrobial agents. Metronidazole.

Mayo Clinic proceedings, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.